title: [My device for operation of esophageal and gastric cancer].
abstract: I employed esophageal reconstruction prior to esophagectomy as a standard surgical procedure. In this procedure, two separate teams perform the operation in the cervical and abdominal regions simultaneously, therefore the operation time is shortened, and we can estimate the degree of lymph node and distant metastasis in each area early in the operation. I applied free ileocolon transfer to 5 patients with cervical esophageal cancer because of voice restoration combined with reconstruction of cervical esophagus. They were able to achieve a fair to good voice, to swallow without aspiration. Since the founding of our institute, we have performed 185 esophagectomies with an operative death rate of 4.3% and 5-year survival rate of 20.4%. I employed ileocolon interposition as a reconstruction in 55 patients after total and proximal partial gastrectomy. In this procedure, reflux esophagitis is prevented by the Bauhin's valve and the colonic segment functions as a gastric reservoir.
authors.affiliation: Second Department of Surgery, Toyama Medical and Pharmaceutical University, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Fujimaki
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004938:Esophageal Neoplasms / Q000473:pathology / Q000601:surgery*; D016629:Esophagectomy; D004944:Esophagoplasty; D005743:Gastrectomy; D006801:Humans; D009367:Neoplasm Staging; D013274:Stomach Neoplasms / Q000473:pathology / Q000601:surgery*
chemical_list: D000970:Antineoplastic Agents